Showing results (361-370 of 369) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 369 results.
Leukemia|May 4, 2016
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic featuresV I Gaidzik, V Teleanu, E Papaemmanuil, et al.
Bone Marrow Transplantation|November 22, 2023
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMTV Potter, L Gras, L Koster, et al.
Annals of the Rheumatic Diseases|May 15, 2001
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin diseaseM Binks, J R Passweg, D Furst, et al.
Leukemia|February 1, 2012
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter studyU Germing, M Lauseker, B Hildebrandt, et al.
Leukemia|February 25, 2017
Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivoA Chaturvedi, L Herbst, S Pusch, et al.
Annals of Hematology|January 18, 2002
Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cellsH D Ottinger, C R Müller, S F Goldmann, et al.
Annals of the Rheumatic Diseases|July 14, 2004
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR RegistryD Farge, J Passweg, J M van Laar, et al.
Leukemia|April 12, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaV Madan, P Shyamsunder, L Han, et al.
Leukemia|August 15, 2017
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinantsR Hehlmann, M Lauseker, S Saußele, et al.
Pageof 37